Plasma Membrane Ca

apoptosis cancer metabolism cell migration pancreatic ductal adenocarcinoma plasma membrane Ca2+ ATPases 4 (PMCA4)

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
16 Jan 2020
Historique:
received: 13 11 2019
revised: 08 01 2020
accepted: 10 01 2020
entrez: 23 1 2020
pubmed: 23 1 2020
medline: 23 1 2020
Statut: epublish

Résumé

Pancreatic ductal adenocarcinoma (PDAC) is largely resistant to standard treatments leading to poor patient survival. The expression of plasma membrane calcium ATPase-4 (PMCA4) is reported to modulate key cancer hallmarks including cell migration, growth, and apoptotic resistance. Data-mining revealed that PMCA4 was over-expressed in pancreatic ductal adenocarcinoma (PDAC) tumors which correlated with poor patient survival. Western blot and RT-qPCR revealed that MIA PaCa-2 cells almost exclusively express PMCA4 making these a suitable cellular model of PDAC with poor patient survival. Knockdown of PMCA4 in MIA PaCa-2 cells (using siRNA) reduced cytosolic Ca

Identifiants

pubmed: 31963119
pii: cancers12010218
doi: 10.3390/cancers12010218
pmc: PMC7016988
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Pancreatic Cancer Research Fund
ID : N/A
Organisme : CONICYT PFCHA/DOCTORADO BECAS CHILE/2018
ID : 72190660
Organisme : Royal Thai Government PhD scholarship
ID : N/A
Organisme : University of Manchester Alumni Association Research Impact Fund and Doctoral Academy PhD scholarship
ID : N/A
Organisme : Nora University PhD scholarship
ID : N/A
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/P00251X/1
Pays : United Kingdom

Références

Mol Biol Cell. 2011 Feb 1;22(3):421-36
pubmed: 21148289
Cell. 2007 Dec 14;131(6):1047-58
pubmed: 18083096
Cancer Res. 2008 Feb 1;68(3):918-26
pubmed: 18245495
Nat Protoc. 2010 May;5(5):929-34
pubmed: 20431538
Cold Spring Harb Perspect Biol. 2011 Feb 01;3(2):
pubmed: 21421919
Int J Cancer. 1975 May 15;15(5):741-7
pubmed: 1140870
Semin Cancer Biol. 2017 Apr;43:74-89
pubmed: 28267587
Cancers (Basel). 2019 Mar 07;11(3):
pubmed: 30866547
Mol Cell Biol. 2001 Dec;21(24):8276-88
pubmed: 11713265
J Biol Chem. 2004 Aug 6;279(32):33742-50
pubmed: 15178683
Biomed Res Int. 2015;2015:409245
pubmed: 25977921
Nature. 2009 Feb 12;457(7231):901-5
pubmed: 19118385
Nat Rev Cancer. 2017 Jun;17(6):367-380
pubmed: 28386091
Semin Cancer Biol. 2017 Jun;44:153-169
pubmed: 28366542
Mitochondrion. 2012 Jan;12(1):77-85
pubmed: 21798374
Carcinogenesis. 2009 Nov;30(11):1962-9
pubmed: 19755660
Support Care Cancer. 2013 Jan;21(1):157-63
pubmed: 22648205
Cell. 2011 Mar 4;144(5):646-74
pubmed: 21376230
Lancet. 2015 Mar 28;385(9974):1206-18
pubmed: 25479696
Biochim Biophys Acta. 2015 Oct;1848(10 Pt B):2502-11
pubmed: 25150047
FASEB J. 1989 Sep;3(11):2298-301
pubmed: 2528493
J Biol Chem. 2015 Oct 9;290(41):24760-71
pubmed: 26294767
Sci Rep. 2016 May 05;6:25505
pubmed: 27148852
Oncogene. 2004 Mar 25;23(13):2385-400
pubmed: 14767473
Physiol Rev. 2001 Jan;81(1):21-50
pubmed: 11152753
J Biol Chem. 2012 Sep 14;287(38):31666-73
pubmed: 22822055
J Med Chem. 2017 Nov 22;60(22):9184-9204
pubmed: 29120638
Cells. 2019 Jan 05;8(1):
pubmed: 30621293
Int J Cancer. 1977 Jan;19(1):128-35
pubmed: 832918
Cell Death Dis. 2013 Jul 04;4:e701
pubmed: 23828564
Cancers (Basel). 2018 Jun 14;10(6):
pubmed: 29903994
Br J Cancer. 2020 Jan;122(2):266-278
pubmed: 31819190
Elife. 2018 Aug 03;7:
pubmed: 30074477
Am J Physiol. 1990 Mar;258(3 Pt 1):C552-62
pubmed: 2156439
Biochem Biophys Res Commun. 2011 Jan 7;404(1):424-7
pubmed: 21130732
Mol Metab. 2019 Jul 27;:
pubmed: 31395464
PLoS One. 2014 Jul 11;9(7):e102352
pubmed: 25014339
J Biol Chem. 2014 Mar 7;289(10):7221-31
pubmed: 24448801
J Biol Chem. 2013 Jan 11;288(2):848-58
pubmed: 23150667
J Biol Chem. 2004 Jul 2;279(27):28220-6
pubmed: 15078889
Cell Death Differ. 2003 Jun;10(6):709-17
pubmed: 12761579
Biochim Biophys Acta. 2009 Aug;1794(8):1175-80
pubmed: 19250982
Cell Calcium. 2018 Jan;69:62-72
pubmed: 28515000
J Biol Chem. 2007 Aug 3;282(31):22298-306
pubmed: 17519236
IUBMB Life. 2010 Nov;62(11):791-6
pubmed: 21117169
J Gen Physiol. 1992 Jan;99(1):21-40
pubmed: 1311020
Clin Oncol (R Coll Radiol). 2008 Sep;20(7):535-40
pubmed: 18346883
J Biol Chem. 2013 Dec 13;288(50):36007-19
pubmed: 24158437
Proc Natl Acad Sci U S A. 2013 Mar 5;110(10):3919-24
pubmed: 23407165
Hepatogastroenterology. 2008 Nov-Dec;55(88):2016-27
pubmed: 19260470
J Cell Biochem. 2016 Feb;117(2):279-88
pubmed: 26206252
EMBO J. 2001 Jun 1;20(11):2680-9
pubmed: 11387203
J Exp Med. 2010 Aug 30;207(9):1825-33
pubmed: 20733032
Structure. 1998 Feb 15;6(2):195-210
pubmed: 9519410
Syst Biol Reprod Med. 2017 Oct;63(5):294-302
pubmed: 28787189
Science. 2017 Aug 18;357(6352):
pubmed: 28818916
Cancer Res. 2008 Apr 1;68(7):2085-93
pubmed: 18381413
Am J Pathol. 1996 Jun;148(6):1763-70
pubmed: 8669463
Mol Vis. 2010 Nov 02;16:2259-72
pubmed: 21139678
Cell Rep. 2019 Oct 1;29(1):135-150.e9
pubmed: 31577944
J Biol Chem. 2014 Apr 11;289(15):10261-8
pubmed: 24570005
Nat Cell Biol. 2014 Feb;16(2):133-44
pubmed: 24463606
Can J Physiol Pharmacol. 2005 Aug-Sep;83(8-9):743-54
pubmed: 16333376
PLoS One. 2018 Sep 24;13(9):e0203965
pubmed: 30248111
EMBO J. 2012 Mar 7;31(5):1123-33
pubmed: 22246182
Cell Death Differ. 2007 Jul;14(7):1285-94
pubmed: 17431416
Front Biosci. 2007 May 01;12:4641-60
pubmed: 17485401
J Biol Chem. 2012 Aug 17;287(34):28598-608
pubmed: 22733819
Cancer Res. 2006 May 15;66(10):5216-23
pubmed: 16707446
Neoplasia. 2013 Oct;15(10):1125-37
pubmed: 24204192
Pharmacol Ther. 2016 Aug;164:152-69
pubmed: 27139518
Nat Protoc. 2006;1(3):1112-6
pubmed: 17406391
Neoplasia. 2004 Jan-Feb;6(1):1-6
pubmed: 15068665
Biochemistry. 2002 Jul 30;41(30):9426-30
pubmed: 12135364
Biochem Biophys Res Commun. 2007 Apr 20;355(4):932-6
pubmed: 17321497
Cell Death Differ. 2005 Nov;12(11):1390-7
pubmed: 15905877
Cell Calcium. 2018 Jan;69:28-36
pubmed: 28625348

Auteurs

Pishyaporn Sritangos (P)

Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester M13 9PT, UK.

Eduardo Pena Alarcon (E)

Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester M13 9PT, UK.

Andrew D James (AD)

Department of Biology, University of York, Heslington, York YO10 5DD, UK.

Ahlam Sultan (A)

Department of Pharmaceutical Science, College of Pharmacy, Princess Nourah Bint Abdulrahman University, Riyadh, Saudi Arabia.

Daniel A Richardson (DA)

Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester M13 9PT, UK.

Jason I E Bruce (JIE)

Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester M13 9PT, UK.

Classifications MeSH